New Treatments for Multiple Sclerosis

Update item information
Identifier 20190319_nanos_newinfo_1_04
Title New Treatments for Multiple Sclerosis
Creator Sashank Prasad, MD
Subject Multiple Sclerosis; Rituximab; Alemtuzumab; Siponimod; Ocrelizumab
Description The era of disease modifying therapy for Multiple Sclerosis (MS), which began with ACTH in the 1950s, has truly accelerated in the past 2 decades. Neuro-ophthalmologists should be aware of the important recent therapeutic advances that will impact their patients with MS.
Relation is Part of NANOS Annual Meeting 2019: New Information I Should Know
Contributor Primary Sashank Prasad, MD
Publisher Spencer S. Eccles Health Sciences Library, University of Utah
Date 2019-03
Format video/mp4
Rights Management Copyright 2019. For further information regarding the rights to this collection, please visit:
Holding Institution North American Neuro-Ophthalmology Association. NANOS Executive Office 5841 Cedar Lake Road, Suite 204, Minneapolis, MN 55416
Language eng
ARK ark:/87278/s60c9brq
Setname ehsl_novel_nam
Date Created 2019-05-30
Date Modified 2019-07-01
ID 1427054
Reference URL
Back to Search Results